Content about Prodrugs

March 24, 2011
Sandoz gets OK for authorized generic of Famvir

Sandoz has introduced an authorized generic version of a herpes treatment made by parent company Novartis, the company said Thursday.

PRINCETON — Sandoz has introduced an authorized generic version of a herpes treatment made by parent company Novartis, the company said Thursday.

Sandoz announced the launch of famciclovir tablets, an authorized generic of Famvir, used to treat genital herpes and cold sores in patients with healthy immune systems, and to treat shingles and herpes simplex infections of the skin and mucosa in patients with HIV.

Authorized generics are branded drugs sold under their generic chemical names at a reduced price, often through third-party companies.

March 22, 2011
Watson introduces generic Famvir

A subsidiary of Watson Pharmaceuticals has launched a treatment for herpes infections, the company said Monday.

MORRISTOWN, N.J. — A subsidiary of Watson Pharmaceuticals has launched a treatment for herpes infections, the company said Monday.

Watson Labs launched famciclovir tablets in the 125-mg, 250-mg and 500-mg strengths. The drug is a generic version of Novartis’ Famvir and is used to treat cold sores and genital herpes in patients with and without HIV.

Famvir and generic versions had sales of about $197 million in 2010, according to IMS Health.

August 10, 2010
FDA approves extended use of Valcyte for kidney transplant patients

The Food and Drug Administration is allowing kidney transplant patients to use a drug for...

July 13, 2010
Mylan's generic arthritis drug receives FDA approval

The Food and Drug Administration has approved a generic arthritis treatment made by Mylan, the...

PITTSBURGH The Food and Drug Administration has approved a generic arthritis treatment made by Mylan, the drug maker said Wednesday.

 

The FDA approved nabumetone tablets, a treatment for osteoarthritis and rheumatoid arthritis, in the 500 mg and 750-mg strengths.

 

 

May 24, 2010
Generic Valtrex to hit the market

Teva Pharmaceuticals has introduced a generic version of a drug for genital herpes, shingles and...

May 2, 2010
Watson confirms patent challenge for Trilipix generic

Drug maker Abbott has sued a Watson Pharmaceuticals subsidiary over its attempt to market a...

March 30, 2010
FDA: Stalevo may increase male patients' risk of cancer

Data from a long-term clinical trial may indicate a possible cancer risk in men taking...

March 29, 2010
Plavix patent upheld by U.S. Patent and Trademark Office

The U.S. Patent and Trademark Office plans to uphold the patent protection of a blockbuster...

March 11, 2010
FDA adds boxed warning to Plavix

A popular drug for preventing blood clots may be less effective when taken by a...

February 8, 2010
Lupin receives FDA approval for Lotrel generic

The Food and Drug Administration has approved a generic hypertension drug made by India-based Lupin...

December 10, 2009
PricewaterhouseCoopers: Personalized medicine market to grow 11% annually

PricewaterhouseCoopers’ report that the personalized medicine market will grow 11% per year is just another...

NEW YORK PricewaterhouseCoopers’ report that the personalized medicine market will grow 11% per year is just another indication that the field could become the next generation of community pharmacy.